autifony

Cochlear Implant Add-on Clinical Trial

Autifony is sponsoring a clinical trial of AUT00063 as add-on therapy for cochlear implant users under the title of “QuicK+fire”. This will be a pilot study with 12 subjects, carried out in the UK. Professor Shakeel Saeed, Chair of Otology and Neuro-Otology at UCL, is the study’s Principal Investigator. This study will explore the potential of Autifony's lead Kv3 modulator, AUT00063, to improve the ability of people with cochlear implants to discriminate speech against a noisy background.

The clinical trial will be conducted at four sites in the UK and is now recruiting.

For more detailed information on the sites participating in our clinical trial and about how to enrol, see our Cochlear Implant Add-on Clinical Trial sites below.

For more information and Frequently Asked Questions, see here.

Further information on this clinical trial is available at ClinicalTrials.gov

Cochlear Implant Add-on Clinical Trial - sites

The following sites are now open and are recruiting in the UK.
Site
Prof Saeed, Royal National Throat, Nose and Ear Hospital, London
Mr Axon, Addenbrooke’s Hospital, Cambridge
Mr Huins, Queen Elizabeth Hospital, Birmingham
Prof Lloyd, Manchester Royal Infirmary, Manchester